跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CAN-001
首页
药物
CAN-001
CAN-001
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS
EP 4177264 A1
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
EP
US
6 件公开
US 10537624 B2
申请人: IMMATICS BIOTECHNOLOGIES GMBH
优先权: 2016
CN
US
2 件公开
THE CO-CULTURE METHOD OF SPHINGOMONAS SP. BACTERIAL STRAIN AND ASPERGILLUS SP. FUNGUS STRAIN, NEW ANTI-CANCER AND ANTIBIOTIC GLIONITRINS DERIVED FROM THIS CO-CULTURE METHOD, AND PHARMACEUTICAL COMPOSITION CONTAINING GLIONITRINS OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT
US 2010215620 A1
申请人: KOREA INST SCI & TECH
优先权: 2007
CN
US
2 件公开
METHOD AND COMPOSITION FOR TREATING CORONA VIRUS, INFLUENZA, AND ACUTE RESPIRATORY DISTRESS SYNDROME
US 20250222024 A1
申请人: REVERSPAH LLC
优先权: 2020
CN
US
2 件公开
HAIR PROTECTION AND REPAIR COMPOSITION
WO 2023154325 A1
申请人: BARNET PRODUCTS LLC
优先权: 2022
CN
WO
2 件公开
Application of compound ICG-001 in preparing hypertension treating medicines
CN 106038568 A
申请人: NANFANG HOSPITAL SOUTHERN MEDICAL UNIV
优先权: 2014
CN
2 件公开
CER-001 therapy for treating kidney disease
US 11752163 B2
申请人: ABIONYX PHARMA SA
优先权: 2021
US
2 件公开
Pseudo-rabies gE/gI-gene loss poison strain, killed vaccine containing it and use
CN 1940063 A
申请人: UNIV HUAZHONG AGRICULTURE
优先权: 2005
CN
Natural liquid shampoo containing lily extracted factor
CN 101450031 A
申请人: SHANGHAI HANSUXIN BIO CHEM TEC
优先权: 2007
CN
Preparation method of Pu-Er ripe tea standard extract PRC-001 and preparation method and use thereof
CN 101380390 B
申请人: KUNMING INST BOTANY CN ACAD
优先权: 2008
CN
Combination therapies
CN 107106687 A
申请人: NOVARTIS AG
优先权: 2014
CN
第 1 / 7 页
上一页
下一页
药物
反馈